16 Dec 2019 --- After weeks of speculation, IFF and DuPont have entered into a definitive agreement for the merger of IFF and DuPont’s Nutrition & Biosciences (N&B) business. The deal values the combined company at US$45.4 billion on an enterprise value basis, reflecting a value of US$26.2 billion for the N&B business based on IFF’s share price as of December 13. The major tie-up, which will simply be called IFF, is projected to create a global leader in high-value ingredients and solutions for global Food & Beverage, Home & Personal Care and Health & Wellness markets, with an estimated 2019 pro forma revenue of more than US$11 billion and EBITDA of US$2.6 billion, excluding synergies.
